Clinical trial
Treatment of Insulin Resistance in Hypertensive, Obese Adolescents
NCT00185705 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00185705 |
|---|---|
| Title | Treatment of Insulin Resistance in Hypertensive, Obese Adolescents |
| Official title | Randomized, Placebo Controlled, Double Blind Trial of Telmisartan in Hypertensive, Obese Adolescents |
| Lead sponsor | Stanford University, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Hypertension, Insulin Resistance, Dyslipidemia |
| Intervention type | Drug |
| Interventions | Telmisartan |
| Enrollment | 30 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: